A1 Refereed original research article in a scientific journal
Challenging Management of Plexiform Schwannoma and Plexiform Neurofibroma
Authors: Nicoli Taija K, Saat Riste, Tarkkanen Jussi, Kinnunen Ilpo, Mäkitie Antti A, Jero Jussi
Publisher: Lippincott Williams & Wilkins
Publication year: 2022
Journal: Journal of Craniofacial Surgery
Journal name in source: The Journal of craniofacial surgery
Journal acronym: J Craniofac Surg
Volume: 33
Issue: 3
First page : 803
Last page: 808
ISSN: 1049-2275
eISSN: 1536-3732
DOI: https://doi.org/10.1097/SCS.0000000000008381
Publication's open availability at the time of reporting: No Open Access
Publication channel's open availability : Partially Open Access publication channel
Web address : https://journals.lww.com/jcraniofacialsurgery/Abstract/9000/Challenging_Management_of_Plexiform_Schwannoma_and.91976.aspx
Self-archived copy’s web address: https://helda.helsinki.fi/handle/10138/351298
Self-archived copy's version: Final draft
Plexiform variants of neurofibromas and schwannomas are rare and typically arise in superficial soft tissues in the head and neck region. The treatment of these tumors is challenging and no generally accepted guidelines exist for their optimal management. The purpose of this study was to review the management and long-term prognosis of head and neck plexiform neurofibromas and schwannomas at 2 tertiary care academic hospitals in Finland over a 31-year period. The pathology files were searched for plexiform neurofibromas and schwannomas between the years 1990 and 2020. The case notes were reviewed for full management details. Two plexiform schwannomas and 6 plexiform neurofibromas were identified. Five of the 6 plexiform neurofibromas were managed operatively. All patients with a surgically managed plexiform neurofibroma underwent multiple operations. Sclerotherapy abolished 1 patient's cutaneous plexiform neurofibromas. The management of plexiform neurofibromas and plexiform schwannomas remains challenging. Sclerotherapy may offer a promising management option for cutaneous plexiform neurofibromas.